Literature DB >> 20580298

Polymerase chain reaction survey of feline haemoplasma infections in Greece.

Iona E Maher1, Séverine Tasker, Zoe Polizopoulou, Anastasia Dasopoulou, Kathy Egan, Christopher R Helps, Kostas Papasouliotis.   

Abstract

The aim of this study was to use real-time polymerase chain reaction assays to determine the prevalence of three haemoplasma species in cats from Greece and to evaluate possible associations between haemoplasma infection and age, gender, feline immunodeficiency virus/feline leukaemia virus (FIV/FeLV) status and packed cell volume (PCV). Ninety-seven cats (24 ill anaemic, 55 ill non-anaemic, 18 healthy non-anaemic) were included in the study. Twenty cats (20.6%) were haemoplasma positive; seven cats were infected only with Mycoplasma haemofelis, 10 were infected only with 'Candidatus Mycoplasma haemominutum' and three were co-infected with M haemofelis and 'Candidatus M haemominutum'. 'Candidatus Mycoplasma turicensis' was not detected. Haemoplasma infection was associated with older age (P=0.019). M haemofelis infection tended to be more common in anaemic cats (P=0.058). No association between gender and haemoplasma infection, or haemoplasma relative copy number and PCV, was detected. Retroviral infection rates were very low with only one FeLV proviral positive cat found. Copyright 2010 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580298     DOI: 10.1016/j.jfms.2010.02.004

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  7 in total

1.  Prevalence study and risk factor analysis of selected bacterial, protozoal and viral, including vector-borne, pathogens in cats from Cyprus.

Authors:  Charalampos Attipa; Kostas Papasouliotis; Laia Solano-Gallego; Gad Baneth; Yaarit Nachum-Biala; Elpida Sarvani; Toby G Knowles; Sena Mengi; David Morris; Chris Helps; Séverine Tasker
Journal:  Parasit Vectors       Date:  2017-03-13       Impact factor: 3.876

2.  Prevalence and risk factor analysis for feline haemoplasmas in cats from Northern Serbia, with molecular subtyping of feline immunodeficiency virus.

Authors:  Elpida Sarvani; Séverine Tasker; Milica Kovacˇević Filipović; Jelena Francuski Andrić; Nenad Andrić; Larissa Aquino; Sarah English; Charalampos Attipa; Christian M Leutenegger; Chris R Helps; Kostas Papasouliotis
Journal:  JFMS Open Rep       Date:  2018-05-22

3.  Prevalence and Risk Factors for Bartonella spp. and Haemoplasma Infections in Cats from Greece.

Authors:  Kassiopi Christina G Kokkinaki; Manolis N Saridomichelakis; Vassilis Skampardonis; Antonia Mataragka; John Ikonomopoulos; Leonidas Leontides; Mathios E Mylonakis; Joerg M Steiner; Jan S Suchodolski; Panagiotis G Xenoulis
Journal:  Vet Sci       Date:  2022-07-03

4.  Molecular detection of hemoplasma infection among cats from São Luís island, Maranhão, Brazil.

Authors:  M S C O Braga; M R André; C R Freschi; M C A Teixeira; R Z Machado
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

5.  Survey of Toxoplasma gondii and Neospora caninum, haemotropic mycoplasmas and other arthropod-borne pathogens in cats from Albania.

Authors:  Cornelia Silaghi; Martin Knaus; Dhimiter Rapti; Ilir Kusi; Enstela Shukullari; Dietmar Hamel; Kurt Pfister; Steffen Rehbein
Journal:  Parasit Vectors       Date:  2014-02-11       Impact factor: 3.876

6.  Epidemiological study of hemotropic mycoplasmas (hemoplasmas) in cats from central Spain.

Authors:  David Díaz-Regañón; Alejandra Villaescusa; Tania Ayllón; Fernando Rodríguez-Franco; Mercedes García-Sancho; Beatriz Agulla; Ángel Sainz
Journal:  Parasit Vectors       Date:  2018-03-20       Impact factor: 3.876

7.  Molecular detection of hemotropic mycoplasmas (hemoplasmas) in domestic cats (Felis catus) in Romania.

Authors:  Mirela Imre; Cristina Văduva; Gheorghe Dărăbuș; Sorin Morariu; Viorel Herman; Judit Plutzer; Tijana Suici; Philippa J P Lait; Kálmán Imre
Journal:  BMC Vet Res       Date:  2020-10-22       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.